Happy founded Pharmaneek in 2011 as a successful healthcare entrepreneur. He brings a hands-on passion for efficient solution delivery, a bias for process automation and an operator’s mentality formed through launching a handful of labor-driven Healthcare startups. He is currently leading a process to exit Access Therapies, Inc, a long-term Physical / Occupational Therapy and Nursing placement agency serving Acute Care, Specialty Outpatient and Physician/Clinic markets, which he co-founded in 2004. Exiting the year on a ~$22MM run rate with bids in hand for an 80x cash-on-cash return to initial investors, Happy is motivated to increase his focus on driving growth and value in Pharmaneek. He holds a BS in Accounting from Indiana University, and worked as a Staff Accountant from 1984 until 1989, the year he launched his first Healthcare startup.
Matt is a founding employee of Pharmaneek and has successfully driven growth and efficiency. He joined in 2011 after serving as Vice President of Wellfount Pharmacy, with prior experience as Director of Automation for acquirer PRN/OmniCare and as GM of Cornerstone Pharmacy. Matt has a BS in Electrical Engineering from Purdue University.
Leo has worked in the IT industry for over 30 years in System Analysis, Programming, and Networking. He also has experience working with MS SQL Server, Oracle, and MySQL. With a degree in B.S. Computer Science, Leo has been a Microsoft Certified Professional and Certified Scrum Master.
John joins us from a Commercial Executive role in Lumiata, Inc, a Blue Cross Venture Partners portfolio company in Silicon Valley that provides AI and predictive analytics. He previously founded and led Stratice Healthcare, a SaaS Healthcare data network solution launched in 2010, raising $10MM, contracting national healthcare providers and driving to successful exit.
Mitch is a Senior Policy Advisor with Bose Public Affairs Group. As a veteran executive with extensive experience in both government and business, he works with clients on a State and Federal level, including the Centers for Medicare and Medicaid Services in Washington, DC, on a variety of issues related to health and economic development. In addition to his policy work, he is President of clinical services firm Healthcare Anywhere, and recently served as president and CEO of Wound Vision, a medical hardware and software technology firm. Mitch held State leadership roles under Indiana Governor Mitch Daniels, which included Secretary of Commerce, where he oversaw $14.3B in corporate investment, CEO of the Indiana Economic Development Corporation, and Secretary of Family & Social Services Administration. Mitch has an MBA from Notre Dame, and a BA in Political Science from DePauw University.
Drug Development/Medical Affairs Senior Physician Executive: Leadership in Major Pharma and Start-Ups
US licensed physician with extensive clinical and pharmaceutical experience:
- Clinical practice experience in Internal Medicine and Obstetrics and Gynecology
- Clinical development experience including three first-in-humans programs and Phase I, II, III and IV clinical trials across therapeutic areas
- IND and NDA experience
- IND enabling pre-clinical and CMC experience
- Medical lead for the launch of a major product in the US
- Establishment of a medical affairs organization
- Establishment of a R&D joint venture company
- International pharmaceutical experience
- Large pharmaceutical company and start-up experience
- Business development, fund raising, and partnership experience
Dr. Kevin Neese is an internist in Indianapolis, Indiana and is affiliated with multiple hospitals in the area, including Community Hospital South and Indiana University Health Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice for more than 20 years.
Sanjay actively advises companies with a focus and passion for innovative solution delivery to materially impact our Healthcare system. For a decade ending 2018, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global market leader in diversified toxicology products, services and POC diagnostics. As the first-mover and consolidator, he grew the business from ~$50MM to ~$650MM, deployed over $1.3B in capital, led a stand-alone division of 2,500+ employees across all major world regions, and drove market-beating organic growth during his decade at Alere. As a member of the company’s executive team reporting to the CEO, he supported Alere’s $5.3 billion sale in 2017 to Abbott Laboratories, Inc (NYSE: ABT). Sanjay has executive experience across In Vitro Diagnostics, Healthcare Services and Information Solutions, and has developed the world-leading business in every healthcare category he has worked in. He held successive leadership positions in the Point-of-Care Diagnostics and Diabetes Care divisions of Roche Diagnostics, Inc. from 2001 to 2008, and within the Specialty Chemicals division of Dow Chemical, Inc. Sanjay has an MBA from Northwestern University, and an undergraduate degree in Industrial Engineering from Purdue University.